featured
news articles

Total number of categories

Total number of articles

Market/Novel Tech

Oxford Biomedica executes an option and license agreement for gene therapy for inherited retinal disease

Oxford Biomedica plc (LSE:OXB) and Santen Pharmaceutical Co., Ltd. (Santen) have entered into an R&D collaboration with an option and licence agreement to develop gene therapy products for the treatment of an inherited retinal disease.  The collaboration is aimed to develop an advanced lentiviral-based gene delivery system to apply to several ophthalmic indications, including wet […]

Read full story
Featured

A prospective study of 5,000 participants indicates that a Mediterranean diet has a 41% reduced risk of incidence of advanced AMD

A combination of two European population-based prospective cohorts has carried out the investigation on the adherence to a Mediterranean diet (“MeDi”).  The adherence to the MeDi was evaluated using a 9-component score, based on intake of (i) vegetables, (ii) fruits, (iii) legumes, (iv) cereals, (v) fish, (vi) meat, (vii) dairy products, (viii) alcohol, and (ix) […]

Read full story
Research

UK’s National Institute for Health Research (NIHR) has reported on the composition and performance of ophthalmology research studies over 8-year period

The UK National Institute for Health Research (NIHR) has reported a high participation of the UK’s hospitals in clinical research ophthalmic studies.  The study reports that there was an average 15,500 patients recruited into studies every year with ongoing improvements in performance.  The purpose of the report was to outline the composition and performance of […]

Read full story
Introduction

July 5th, 2019: “EURETINA-Brief”© Issue No. 195

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the July 5th, 2019 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”.  EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Research

Five-year outcomes of retinal vein occlusion provide long term data for anti-VEGF treatments on real-world data

Researchers at the Sydney Institute of Vision Science, in New South Wales, Australia report that good long-term efficacy of anti-VEGF therapy over 5 years provides a real-world setting, albeit different to the outcome data reported from clinical trial publications. In follow-up to real-world 5-year outcome data on a retrospective population, the results indicate that a […]

Read full story
Introduction

April 16th, 2019: “EURETINA-Brief” Issue No. 190

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the April 16th, 2019 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”.  EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story

Latest News

Book Review